USPTO rejects new reexamination request against Celyad’s US Patent for Production of Allogeneic TCR-Deficient CAR … – GlobeNewswire (press release)
|
USPTO rejects new reexamination request against Celyad's US Patent for Production of Allogeneic TCR-Deficient CAR …
GlobeNewswire (press release) “This is the fourth time that our US Patent for Production of Allogeneic TCR-Deficient CAR–T cells is challenged and each time, the USPTO has been favorable to Celyad. This patent is key for the players that are developing in the US allogeneic CAR–T … |
